Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yiling Xu
Kinase Inhibitor Sorafenib Modulates Immunosuppressive Cell Populations in a Murine Liver Cancer Model
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Related publications
Hematein, a Casein Kinase II Inhibitor, Inhibits Lung Cancer Tumor Growth in a Murine Xenograft Model
International Journal of Oncology
Cancer Research
Oncology
Stimulatory Effects of the Multi-Kinase Inhibitor Sorafenib on Human Bladder Cancer Cells
British Journal of Pharmacology
Pharmacology
Mesenchymal Stem Cell Therapy Modulates Synovial Macrophages in a Murine Model of Osteoarthritis
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Correction: Synergistic Interaction Between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer CellsIn VitroandIn Vivo
Clinical Cancer Research
Cancer Research
Oncology
Visualizing Cancer Cell Dynamics in a Liver Slice Model
Microscopy and Microanalysis
Instrumentation
Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis
Frontiers in Medicine
Medicine
Pan-Tam Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-Pd-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer
Cancer Research
Cancer Research
Oncology
Increased Intratumoral Fluorothymidine Uptake Levels Following Multikinase Inhibitor Sorafenib Treatment in a Human Renal Cell Carcinoma Xenograft Model
Oncology Letters
Cancer Research
Oncology
Immunosuppressive Effect of B7-H4 Pathway in a Murine Systemic Lupus Erythematosus Model
Frontiers in Immunology
Allergy
Immunology
